Lonza Bioscience — Authorized Distributor, GCC & Middle East

Optimized culture systems pairing basal media with SingleQuots™ supplements for endothelial (EGM™-2), fibroblast (FGM™-3), smooth muscle (SmGM™-2), and airway epithelial (BEGM™) primary cells.

X-VIVO™ 15 is the gold standard serum-free medium for T-cell, NK-cell, and dendritic cell expansion — widely cited in CAR-T and immunotherapy clinical trial literature.

Used in FDA-approved therapies and 130+ global clinical trials. AmpliCell® Cytokines for immune cell activation, 293-GT® Medium for high-yield AAV viral vector production.

High-density CHO, Hybridoma, NS0, and insect cell production media. Available in research to 10,000L GMP-grade volumes.

A substantial share of drug-candidate attrition stems from toxicities not recognized until late in clinical trials, driving up development costs. Understanding ADME-Tox (absorption, distribution, metabolism, excretion & toxicity) is central to early discovery — our portfolio spans hepatotoxicity, nephrotoxicity, respiratory, dermal & neurotoxicity models built on primary human cells and predictive in vitro assays.

ViaLight™ ATP bioluminescence counts live cells — proliferation, viability and cytotoxicity down to 10 cells per well in under 20 minutes, faster and more sensitive than MTT-type dye assays. ToxiLight™ detects dead cells through adenylate kinase release, non-destructively, so the remaining cells can be assayed further. Both read on a microplate luminometer or the Lucetta™ 2.

Primary cells, isolated directly from tissue, retain donor-specific characteristics — age, medical history & disease state — with low genetic mutation and close resemblance to native tissue biology, unlike immortalized cell lines. Our portfolio spans 100+ human & animal cell types across 20+ donors, paired with BulletKit® media formulated with the growth factors and hormones needed to preserve tissue-specific phenotype and consistent growth.